Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
Date | Price Target | Rating | Analyst |
---|---|---|---|
5/13/2025 | $7.00 | Neutral | B. Riley Securities |
4/30/2025 | $6.50 | Neutral → Sell | Compass Point |
12/17/2024 | $8.25 | Sell → Neutral | Compass Point |
2/28/2024 | Buy → Neutral | Ladenburg Thalmann | |
1/8/2024 | $11.00 | Neutral → Sell | B. Riley Securities |
10/17/2023 | $10.00 | Neutral → Sell | Compass Point |
9/27/2023 | $11.00 → $10.50 | Sell → Neutral | Compass Point |
8/4/2023 | $11.00 | Neutral → Sell | Compass Point |
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
425 - Horizon Technology Finance Corp (0001487428) (Subject)
8-K - Horizon Technology Finance Corp (0001487428) (Filer)
3 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
4 - Horizon Technology Finance Corp (0001487428) (Issuer)
B. Riley Securities resumed coverage of Horizon Technology Finance with a rating of Neutral and set a new price target of $7.00
Compass Point downgraded Horizon Technology Finance from Neutral to Sell and set a new price target of $6.50
Compass Point upgraded Horizon Technology Finance from Sell to Neutral and set a new price target of $8.25
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that its board of directors has declared monthly cash distributions of $0.11 per share, payable in each of October, November and December 2025. The following tables show these distributions, payable as set forth in the tables below, total $0.33 per share. Since its 2010 initial public offeri
- Second Quarter 2025 Net Investment Income per Share of $0.28; NAV per Share of $6.75 - - Debt Portfolio Yield of 15.8% - - HRZN Ends Quarter with Committed Backlog of $149 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through December 2025 - - Announced Merger with Monroe Capital Corp (NASDAQ:MRCC) - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and serv
Monroe Capital Corporation Additionally Signs Definitive Asset Purchase Agreement to Sell its Investment Assets to Monroe Capital Income Plus Corporation Immediately Preceding Merger Transaction to Drive Scale and Shareholder Value Across Monroe Capital BDC Platforms Monroe Capital LLC ("Monroe Capital") today announced that Monroe Capital Corporation (("MRCC", NASDAQ:MRCC) and Horizon Technology Finance Corporation (("HRZN", NASDAQ:HRZN), both business development companies ("BDCs") managed by affiliates of Monroe Capital, have entered into an agreement (the "Merger Agreement") under which MRCC would merge with and into HRZN (the "Merger"), subject to the receipt of certain shareholder
- Second Quarter 2025 Net Investment Income per Share of $0.28; NAV per Share of $6.75 - - Debt Portfolio Yield of 15.8% - - HRZN Ends Quarter with Committed Backlog of $149 Million - - Declares Regular Monthly Distributions Totaling $0.33 per Share through December 2025 - - Announced Merger with Monroe Capital Corp (NASDAQ:MRCC) - Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and serv
Monroe Capital Corporation Additionally Signs Definitive Asset Purchase Agreement to Sell its Investment Assets to Monroe Capital Income Plus Corporation Immediately Preceding Merger Transaction to Drive Scale and Shareholder Value Across Monroe Capital BDC Platforms Monroe Capital LLC ("Monroe Capital") today announced that Monroe Capital Corporation (("MRCC", NASDAQ:MRCC) and Horizon Technology Finance Corporation (("HRZN", NASDAQ:HRZN), both business development companies ("BDCs") managed by affiliates of Monroe Capital, have entered into an agreement (the "Merger Agreement") under which MRCC would merge with and into HRZN (the "Merger"), subject to the receipt of certain shareholder
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("HRZN" or "Horizon"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity-backed companies and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it plans to release financial results for the second quarter ended June 30, 2025 on Thursday, August 7, 2025, after the close of market trading. The Company has scheduled a conference call to discuss the results on Thursday, August 7, 2025, at 5:00 p.m. ET. The conference call will feature
Horizon Technology Finance Corporation (NASDAQ:HRZN) ("Horizon" or "HRZN") (the "Company"), an affiliate of Monroe Capital, and a leading specialty finance company that provides capital in the form of secured loans to venture capital and private equity backed and publicly traded companies in the technology, life science, healthcare information and services, and sustainability industries, announced today that it has appointed Paul Seitz as its new Chief Investment Officer. Concurrently, Daniel Devorsetz has stepped down as Chief Operating Officer and Chief Investment Officer, but will remain involved with the Company through September 2025. "We are thrilled to welcome Paul as our new Chi
Vesta Healthcare, a virtual care provider group for people with home care, today announced the close of $65 million in a Series C round with new debt financing. The equity round was led by Boston-based RA Capital Management, with participation from Oak HC/FT, Chrysalis Ventures, CareCentrix/Walgreens, Nationwide, Kaiser Permanente Ventures, Lux Capital, Generator Ventures, Deerfield Management and others. Debt financing was provided by Horizon Technology Finance Corporation, an affiliate of Monroe Capital. "The home is the last frontier of healthcare, and caregivers are the most vital yet disconnected resource in the delivery system," said Randy Klein, CEO of Vesta Healthcare. "We're pr
FARMINGTON, Conn., June 9, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon," or the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and services, and sustainability industries, today announced that it has appointed Daniel S. Devorsetz as Chief Operating Officer effective immediately. In addition, Devorsetz has concurrently been appointed as Chief Operating Officer of Horizon's external investment advisor, Horizon Technology Finance Management LLC (the "Advisor" or "HTFM"). He currently serves as Chief Investment Of